Intensive versus moderate lipid lowering with statins in acute coronary syndromes.
Farmer
John A
JA
D000293:Adolescent; D000789:Angina, Unstable / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D008078:Cholesterol, LDL / Q000097:blood; D004305:Dose-Response Relationship, Drug; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D017035:Pravastatin / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin; D017035:Pravastatin
N Engl J Med. 1996 Oct 3;335(14):1001-9
8801446
JAMA. 2004 Mar 3;291(9):1071-80
14996776
N Engl J Med. 2004 Apr 8;350(15):1495-504
15007110
Lancet. 1994 Nov 19;344(8934):1383-9
7968073
JAMA. 2001 Apr 4;285(13):1711-8
11277825